Risk of thromboembolic phenomena in patients with inflammatory bowel disease

被引:8
作者
Suarez Ferrer, Cristina [1 ]
Vera Mendoza, Maria Isabel [1 ]
Amo San Roman, Leticia [1 ]
Gonzalez Lama, Yago [1 ]
Calvo Moya, Marta [1 ]
Garcia Casas, Mercedes [1 ]
Abreu Garcia, Luis [1 ]
机构
[1] Hosp Univ Puerta de Hierro, Serv Gastroenterol & Hepatol, Madrid, Spain
来源
GASTROENTEROLOGIA Y HEPATOLOGIA | 2012年 / 35卷 / 09期
关键词
Thromboembolic phenomena; Inflammatory bowel disease; Risk of thrombosis; DEEP-VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; PULMONARY-EMBOLISM;
D O I
10.1016/j.gastrohep.2012.07.003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Introduction: Inflammatory bowel disease (IBD) is an independent risk factor for thromboembolic phenomena (TEP). We evaluated the prevalence and the possible risk factors associated with developing TEP in patients with IBD in our center. Material and methods: Data were retrospectively collected from January 1995 to December 2011 from 23 patients. A total of 61% were diagnosed with Crohn's disease (CD) and 39% with ulcerative colitis (UC) according to routine criteria. Results: When the Montreal classification was used, 58% of the patients with CD had an inflammatory pattern (B1), 25% a stenosing pattern (B2) and 17% a fistulizing pattern (B3). Half the patients had ileocolic involvement (L3), one-third had colonic involvement (L2) and the remainder had Heal involvement (L1). Among patients with UC according to the Montreal classification, 78% had extensive colitis (E3), 11% had left colonic involvement (E2) and 11% had proctocolitis (El). During the event, almost half the patients with UC had severe inflammatory activity (S3; 44%), 33% had mild-moderate activity (51: 22%, S2: 11%) and only 22% were in remission (SO). Overall, at the time of the TEP, 48% of the patients had mild-moderate activity and 22% had severe activity. Likewise, 44% were hospitalized at the time of the event. In UC, an increase in the prevalence of TEP was found in admitted patients (66%). None of the patients had a family history of TER two patients (9%) had associated thrombophilia and 26% were active smokers. There were no TEP during pregnancy. Only one patient was taking contraceptive pills when the event occurred. The most frequent forms of TEP were deep vein thrombosis of the legs (55%) followed by pulmonary thromboembolism (25%). Conclusions: TEP are relatively frequent in patients with IBD, with a strong impact on morbidity and mortality. In our series, risk factors for these events were more extensive involvement (any of the groups) and severe inflammatory activity. No significant association between classical risk factors such as the use of contraceptives, pregnancy, coagulation disorders or smoking and the risk of TEP were found. (C) 2012 Elsevier Espana, S.L. and AEEH y AEG. All rights reserved.
引用
收藏
页码:634 / 639
页数:6
相关论文
共 50 条
[41]   Thromboembolic and atherosclerotic cardiovascular events in inflammatory bowel disease: epidemiology, pathogenesis and clinical management [J].
Sleutjes, Jasmijn A. M. ;
van Lennep, Jeanine E. Roeters ;
van der Woude, C. Janneke ;
de Vries, Annemarie C. .
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2021, 14
[42]   Risk of drug interactions in population of patients with inflammatory bowel disease [J].
Cerveny, Petr ;
Vlcek, Jiri ;
Lukas, Milan ;
Bortlik, Martin .
PHARMACY WORLD & SCIENCE, 2009, 31 (01) :127-127
[43]   Food Beliefs and the Risk of Orthorexia in Patients with Inflammatory Bowel Disease [J].
Di Giorgio, Francesca Maria ;
Modica, Stefania Pia ;
Saladino, Marica ;
Muscarella, Stefano ;
Ciminnisi, Stefania ;
Almasio, Piero Luigi ;
Petta, Salvatore ;
Cappello, Maria .
NUTRIENTS, 2024, 16 (08)
[44]   Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases [J].
Halling, Morten L. ;
Kjeldsen, Jens ;
Knudsen, Torben ;
Nielsen, Jan ;
Hansen, Lars Koch .
WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (33) :6137-6146
[45]   Spotlight on Cardiovascular Risk Assessment in Patients with Inflammatory Bowel Disease [J].
Sleutjes, Jasmijn A. M. ;
Roeters van Lennep, Jeanine E. ;
de Vries, Annemarie C. .
DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (09) :4326-4329
[46]   Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases [J].
Morten L Halling ;
Jens Kjeldsen ;
Torben Knudsen ;
Jan Nielsen ;
Lars Koch Hansen .
World Journal of Gastroenterology, 2017, (33) :6137-6146
[47]   The Demographic Data and Prevalence of Thromboembolic Events Among Inflammatory Bowel Disease Patients in Buraydah, Al-Qassim Region [J].
Alodheilah, Arwa A. ;
Alnujeidi, Omar A. ;
AlDhuwayhi, Nada A. ;
AlDhilan, Maha M. ;
Alsultan, Fatimah S. ;
Aldhuwayhi, Majd I. ;
Alnumayr, Haya S. ;
AlHotan, Fai M. ;
Aljamaan, Shatha E. .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (09)
[48]   Risk Factors for Hidradenitis Suppurativa in Patients with Inflammatory Bowel Disease [J].
Alexis J. Lukach ;
Melissa I. Saul ;
Laura K. Ferris ;
Jason M. Swoger .
Digestive Diseases and Sciences, 2018, 63 :755-760
[49]   Risk Factors for Hidradenitis Suppurativa in Patients with Inflammatory Bowel Disease [J].
Lukach, Alexis J. ;
Saul, Melissa I. ;
Ferris, Laura K. ;
Swoger, Jason M. .
DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (03) :755-760
[50]   IS THERE A RISK FOR LYMPHOMA OR EXTRACOLONIC CANCER IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE? [J].
Toader, Elena ;
Ciortescu, Irina .
MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2013, 117 (02) :368-374